Following the release of the OTC hearing aid regulations by the FDA on Tuesday 16 August, GN have announced their support of the ambition to help more people access hearing aids. GN will now seek to register the Jabra Enhance Plus technology as an OTC product, allowing consumers to buy the revolutionary earbud-style product online and in retail stores, expanding current availability within ReSound and Beltone hearing care clinics.
By launching Jabra Enhance Plus under the new OTC hearing aid regulation, GN intends to make this innovative hearing health solution more widely accessible, helping a new audience to take the first step on their hearing health journey.
FURTHER INFORMATION:
OTC/Jabra Enhance:
W: https://www.jabra.com/hearing/enhance-plus
